Alector, Inc. Total Assets
Alector, Inc. (ALEC) had Total Assets of $202.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $202.85M.
- 2026-03-31: Assets $239.92M.
- 2025-12-31: Assets $293.24M.
- 2025-09-30: Assets $335.29M.
| Period end | Assets |
|---|---|
| 2026-06-30 | $202.85M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $239.92M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $293.24M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $335.29M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $356.42M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $408.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $468.30M 10-K · filed 2026-02-25 |
| 2024-09-30 | $516.02M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $570.73M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $635.49M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $621.83M 10-K · filed 2025-02-26 |
| 2023-09-30 | $672.39M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $708.74M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $748.34M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $787.65M 10-K · filed 2024-02-27 |
| 2022-09-30 | $837.04M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $889.67M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $954.46M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $814.66M 10-K · filed 2023-02-28 |
| 2021-09-30 | $854.23M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $397.11M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $440.36M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $488.25M 10-K · filed 2022-02-24 |
| 2020-09-30 | $531.59M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $572.03M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $618.93M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $421.91M 10-K · filed 2021-02-25 |
| 2019-09-30 | $449.73M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $477.25M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $496.04M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $308.36M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |